Brief report · 28 Nov 2023
EditorialPublished 28 Mar 2022
Economic and Humanistic Burden of Triple-negative Breast Cancer
Keywords
Subjects
Pharmaceutical SciencesSimilar by topic
Perspective · 30 Jan 2025
Personalized Treatment Approaches in Metastatic Triple-negative Breast Cancer: A Pharmacists Perspective
Research article · 28 Feb 2023
Neoadjuvant Clinical Trials Update for Triple-Negative Breast Cancer
Perspective · 30 Jan 2023
Pharmacist's Perspective: Current Therapeutic Strategies for Metastatic Triple-Negative Breast Cancer
Short communication · 6 Jul 2021
Effect of doxorubicin / cyclophosphamide-based therapy plus IMMUNEPOTENT CRP on the tumor microenvironment in a murine model of triple-negative breast cancer
More from this journal
The newest in Pharmacoeconomics: Open Access.
Opinion · 1 Dec 2025
Drug Repurposing: Economic Gains, Faster Pathways, Rare Diseases
Short communication · 1 Dec 2025
Preventive Drugs for Older Adults: Health and Economic Benefits
Brief report · 29 Nov 2025
Value Assessment Of High-cost Specialty Drugs
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPharmacoeconomics: Open Access
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Patrich J. Welch”

